Kathmere Capital Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1794543 WAYNE, PA

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$3,384,269

-$437,953 QoQ

Shares Held

26,787

-2.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

#682

of 2,266 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kathmere Capital Management, LLC holds $38,480,404 across 14 Drug Manufacturers - General names. GILD ranks #5 (8.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	46,204	$11,734,429
2	LLY	ELI LILLY & Co	4,626	$5,548,563
3	MRK	Merck & Co., Inc.	30,944	$3,976,304
4	NVS	Novartis AG	22,990	$3,602,992
5	GILD	Gilead Sciences, Inc. This page	26,787	$3,384,269
6	BMY	Bristol Myers Squibb Co	37,197	$2,143,291
7	ABBV	AbbVie Inc.	7,045	$1,772,803
8	BIIB	Biogen Inc.	7,285	$1,573,997

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,384,269	26,787	-2.3%	Shares	Sole	2026-07-29
2026-03-31	$3,822,222	27,425	-2.9%	Shares	Sole	2026-04-28
2025-12-31	$3,467,036	28,247	+6.6%	Shares	Sole	2026-01-13
2025-09-30	$2,940,279	26,489	+6.0%	Shares	Sole	2025-10-22
2025-06-30	$2,769,421	24,979	+14.4%	Shares	Sole	2025-07-16
2025-03-31	$2,446,051	21,830	+24.6%	Shares	Sole	2025-05-01
2024-12-31	$1,618,968	17,527	+42.7%	Shares	Sole	2025-01-14
2024-09-30	$1,029,639	12,281	+22.6%	Shares	Sole	2024-10-15
2024-06-30	$687,129	10,015	+237.9%	Shares	Sole	2024-08-15
2024-03-31	$217,113	2,964	+18.4%	Shares	Sole	2024-04-16
2023-12-31	$202,849	2,504	-9.8%	Shares	Sole	2024-04-16
2023-03-31	$230,324	2,776	—	Shares	Sole	2023-04-20
No filing history on record for this holder in this stock.